Rising demand for monoclonal antibodies is a key factor driving market growth

Technavio’s analysts have identified the growing demand for monoclonal antibodies that are identical immune cells as a major factor that will drive this market during the forecast period. Several types of transfection methods in the areas of biology, medicine, and biochemistry adopt the application of monoclonal antibodies. Growing adoption of various types of transfection methods across the world is likely to further drive demand for transfection technologies. These driving factors are part of the reason why the market is expected to grow at a CAGR of nearly 9%. For a complete list of drivers influencing the market’s growth, purchase Technavio’s full report.

Want to know what goes into a Technavio report?   Get a FREE sample to see selected illustrations and analysis straight from this report.

Agilent Technologies, Bio-Rad Laboratories, and Lonza are among leading vendors in the transfection technologies market

The global transfection technologies market is concentrated with international and regional companies that offer products for different types of transfection methods for pharmaceutical and biotechnology companies, contract research organizations (CRO), and academic and research institutes. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this transfection technologies industry analysis report will aid clients identify new growth opportunities and design new growth strategies.

The report offers a complete analysis of a number of companies, including:

• Agilent Technologies
• Bio-Rad Laboratories
• Lonza
• Promega
• QIAGEN
• Thermo Fisher Scientific

The Americas will be the primary driver of growth during the forecast period

Technavio’s market research report covers the following regions:

• Americas
• EMEA
• APAC

Almost 45% of the market’s incremental growth is expected to come from the Americas over the next five years. North America will dominate the market in this region, driven by factors such as increasing cases of infectious diseases demanding the need of antibiotics and growing use of cell-based products which require transfection methods to treat chronic diseases such as cancer, tuberculosis, and cardiovascular diseases.

Pharmaceutical and biotechnology companies lead the market by end-user segment

The global transfection technologies market can be divided into 3 end-user categories:

• Pharmaceutical and biotechnology companies
• Contract research organizations
• Academic and research institutes

In 2017, the pharmaceutical and biotechnology companies segment accounted for the largest share of the market, contributing almost 44% to it. Rising need for different types of transfection methods will mean that this segment will continue to dominate the market throughout the forecast period. The increasing cases of infectious diseases and chronic disorders are expected to drive the growth of the market. This report also examines the contributions of the other product segments to the growth of the market and offers predictions for their future performance.

Key highlights of the global transfection technologies market for the forecast years 2018-2022:

• CAGR of the market during the forecast period 2018-2022
• Detailed information on factors that will accelerate the growth of the transfection technologies market during the next five years
• Precise estimation of the transfection technologies market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• Growth of the transfection technologies industry across various geographies such as the Americas, EMEA, and APAC
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive information about factors that will challenge the growth of transfection technologies companies

Technavio also provides customized reports based on the specific requirement of our clients